Immuno-Oncology Overview
Clinical and biomarker discovery studies are aggressively investigating many areas of immuno-oncology including cancer vaccines, checkpoint inhibitors, adoptive T cell transfer, combination therapies, and biomarkers for predicting patient response. ACE ImmunoID is a comprehensive immunogenomics platform that enables researchers to overcome the following challenges of complex immuno-oncology research: Discovery of neoantigens, biomarkers, and genomic signatures. [...]